Strong Fee-Related Earnings
Reported fee-related earnings of $0.98 per share, total operating earnings of $1.33 per share, and adjusted net income of $1.18 per share, among the highest in KKR's history.
Significant Management Fee Growth
Management fees increased by 18% year-over-year, driven by fund activations and continued fundraising initiatives.
Robust Investment Performance
Private equity portfolio up 5% in the quarter and 13% over the last 12 months; Infrastructure appreciated 14% over the last 12 months.
Strong Capital Deployment
Deployed nearly $37 billion of capital year-to-date, with a healthy pipeline for the second half of 2025.
Successful Fundraising
Raised $28 billion in Q2 across asset classes, with significant growth in the asset-based finance drawdown fund.
Strategic Expansion in Life Sciences
Acquisition of a majority stake in HealthCare Royalty Partners, enhancing biopharma royalty investing capabilities.